Dawnrays Pharmaceutical Holdings Ltd. announced that Ms. Huang Dongmei resigned as the Chief Executive Officer with effect from 1 March 2015; and (ii) Ms. Li Kei Ling was appointed as the Chief Executive Officer with effect from 1 March 2015. Ms. Li is also an executive director and the chairman of the Board of the company.